[1]Hardy J. Alzheimer’s disease: the amyloid cascade hypothesis: an update and reappraisal[J]. J Alzheimers Dis, 2006, 9(3 Suppl): 151-153.
[2]Cui M C. Past and Recent Progress of Molecular Imaging Probes for beta-Amyloid Plaques in the Brain[J]. Curr Med Chem, 2014, 21(1): 82-112.
[3]Newberg A B, Wintering N A, Plossl K, et al. Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer’s disease[J]. J Nucl Med, 2006, 47(5): 748-754.
[4]Nesterov E E, Skoch J, Hyman B T, et al. In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers[J]. Angew Chem Int Ed Engl, 2005, 44(34): 5452-5456.
[5]Aslund A, Sigurdson C J, Klingstedt T, et al. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidosis[J]. ACS Chem Biol, 2009, 4(8): 673-684.
[6]Cui M C, Li Z J, Tang R K, et al. Synthesis and evaluation of novel benzothiazole derivatives based on the bithiophene structure as potential radiotracers for beta-amyloid plaques in Alzheimer′s disease[J]. Bioorg Med Chem, 2010, 18(7): 2777-2784.
[7]Cui M C, Li Z J, Tang R K, et al. Novel (E)-5-styryl-2,2′-bithiophene derivatives as ligands for beta-amyloid plaques[J]. Eur J Med Chem, 2011, 46(7): 2908-2916.
[8]Ono M, Haratake M, Mori H, et al. Novel chalcones as probes for in vivo imaging of beta-amyloid plaques in Alzheimer’s brains[J]. Bioorg Med Chem, 2007, 15(21): 6802-6809.
[9]Ono M, Watanabe R, Kawashima H, et al. Fluoro-pegylated chalcones as positron emission tomography probes for in vivo imaging of beta-amyloid plaques in Alzheimer’s disease[J]. J Med Chem, 2009, 52(20): 6394-6401.
[10]Cui M C, Ono M, Kimura H, et al. Synthesis and biological evaluation of indole-chalcone derivatives as beta-amyloid imaging probe[J]. Bioorg Med Chem Lett, 2011, 21(3): 980-982.
[11]Cheng Y, Prusoff W H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction[J]. Biochem Pharmacol, 1973, 22(23): 3099-3108. |